Jay S. Skyler, MD, MACP is currently a Professor of Medicine, Pediatrics, & Psychology, in the Division of Endocrinology Diabetes & Metabolism, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, Florida. He served as Director of that Division from 2000 to 2004. He is Deputy Director for Clinical Research and Academic Programs at the Diabetes Research Institute, University of Miami, where he previously was Area Leader for Immunomodulation and Tolerance. He also is a Member of the University of Miami Interdisciplinary Stem Cell Institute. He was Program Director of UM’s NIH General Clinical Research Center (GCRC) from 2001 to 2006. He was chairman of the faculty planning committee for the University’s Clinical Research Building, a 336,000 square foot facility which opened in 2006. He also is an Adjunct Professor of Pediatrics at the Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver. From 1993 until 2015, he was Chairman of the NIH (NIDDK)-sponsored Diabetes Prevention Trial – Type 1 (DPT-1) and its successor Type 1 Diabetes TrialNet, a nationwide (and global) network conducting clinical trials to interdict type 1 diabetes. Dr. Skyler currently is Chair of the Strategy Advisory Group for INNODIA, a European consortium of academic and industry groups developing innovative approaches towards understanding and arresting type 1 diabetes.